Matrix metalloproteinases (MMPs) in oral diseases.

By T. Sorsa, L. Tjäderhane, Tuula Salo. Oral Diseases, 2004

650 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Periodontics

View Paper: https://www.semanticscholar.org/paper/a56c75959e66f3a87dce06d61fb41000ab977171

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. G. Opdenakker

In Oncology

1. G. Opdenakker

Citations in the corpus

• In vivo Preservation of the Hybrid Layer by Chlorhexidine (2007, background): “Synthetic MMP inhibitors are being investigated as potential therapeutic agents in the treatment and/or prevention of oral diseases (Sorsa et al., 2004).”
• Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases (2007, background): “Originally, microbial proteases were held responsible, but increasing evidence indicates that host MMPs, mainly MMP8 and MMP9, are essential in these processes (reviewed by Sorsa et al”
• Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation (2006, background): “The mechanisms involved in the initiation and progression of periodontal diseases are not clearly understood (28,64,75).”